Bruker Daltonics Inc. (BDAL) And SERVA Electrophoresis GmbH Announce Co-Marketing Agreement On ICPL Protein Quantitation Technology For Proteomics
10/19/2005 5:08:44 PM
SAN ANTONIO--(BUSINESS WIRE)--June 6, 2005--At the 2005 ASMS Conference, Bruker Daltonics Inc. and Serva Electrophoresis GmbH today announce their new co-marketing agreement, and present the ICPL(TM) stable isotope labeling technology developed by Drs. Friedrich Lottspeich and Josef Kellermann at the Max-Planck-Institute of Biochemistry in Martinsried, Germany.
comments powered by